org placeholder image

Thomas Luke

SVP Research and Development at SAb Biotherapeutics

  • LinkedIn
map
SAB BIOTHERAPEUTICS

SAB BIOTHERAPEUTICS

  • description Description
    A clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of typ...

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 50 Million to 100 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

SAb Biotherapeutics Org Chart and Mapping

Employees

Allison Braun

Senior Research Associate

Katrina Mellegard

Research Associate 2 Quality Control

Sivakumar Nadarajah

Executive Director, Quality Control

Ema Althoff

Senior Research Associate II

Thomas Luke

SVP Research and Development

Melissa Ullerich

Chief Corporate Communications & Investor Relations Officer

Daniel Vermeer

Senior Oncology Immunotherapies Manager

Frequently Asked Questions Regarding Thomas Luke

Answer: Thomas Luke works for SAb Biotherapeutics as SVP Research and Development

Answer: Thomas Luke’s role in SAb Biotherapeutics is SVP Research and Development

Answer: Thomas Luke's email address is t***@gmail.com

Answer: Thomas Luke's business email address is t****@sabbiotherapeutics.com

Answer: Thomas Luke’s direct phone number is (***)-***-****

Answer: Thomas Luke works in the industry of: Pharmaceuticals

Answer: Thomas Luke works SAb Biotherapeutics located at 2100 E 54th St N, Sioux Falls, South Dakota, 57104, United States

Answer: SAb Biotherapeutics's SVP Research and Development is Thomas Luke

Answer: Thomas Luke contact details:

  • Phone number  :  (***)-***-****
  • Email  :  t****@sabbiotherapeutics.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access